Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...

Gypsy-Rose Blanchard is setting the record straight when it comes to rumors circulating about her baby daughter Aurora Raina ...

Gypsy-Rose Blanchard is setting the record straight when it comes to rumors circulating about her baby daughter Aurora Raina ...

Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were takin Wegovy ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

An ideal Mounjaro diet plan should focus on nutrient-dense foods, such as fruits, vegetables, whole grains, lean proteins, ...

Weight-loss drug developer Metsera on Monday said it was is targeting to raise as much as $292.2 million in an initial public offering.

With GLP-1-related drugs having won the race to weight loss approval, attention at many obesity-focused biopharmas has turned ...

Veru said on Monday its experimental drug, in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the main goal of a mid-stage ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

Kennedy is nominated to lead the Department of Health and Human Services, a position that would give him enormous control ...

Doctors say that for many patients, these medications help them get control of their obesity and other weight-related medical issues, along with improving their blood sugar and heart health. However, ...